2035. Deputy Ken O'Flynn asked the Minister for Health the estimated annual Exchequer cost of extending full public sector pay parity, pension arrangements, and conditions to all Section 39 disability service staff funded by the HSE; whether modelling or scenario analysis has been carried out; and if she will make a statement on the matter. [42448/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
2,439 questions match, newest first.
2036. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or Department of Health maintains a national breakdown of working hours, paid breaks, unpaid breaks, and average rostered hours across all public health service staff categories; if so, to provide details by staff category and service area; and if she will make a statement on the matter. [42449/26]
2037. Deputy Ken O'Flynn asked the Minister for Health whether any categories of public health service staff currently work roster patterns or contracted arrangements which bring average weekly working hours close to or above the limits set out under the Organisation of Working Time Act 1997; whether any exemptions, derogations, or compliance concerns have been identified; and if she will make a statement on the matt…
2038. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any audit, compliance review, or governance assessment regarding adherence to Organisation of Working Time Act 1997 obligations across HSE-funded services, including Section 38 and Section 39 organisations; if so, to provide details and findings; and if she will make a statement on the matter. [42451/26]
2039. Deputy Ken O'Flynn asked the Minister for Health whether unpaid break arrangements across public health service grades have been assessed in terms of their impact on recruitment, retention, fatigue management, and workforce wellbeing; and if she will make a statement on the matter. [42452/26]
2040. Deputy Ken O'Flynn asked the Minister for Health whether any national policy differences exist regarding working hours, rest breaks, or overtime arrangements between directly employed HSE staff and employees in Section 38 and Section 39 organisations providing publicly funded disability services; and if she will make a statement on the matter. [42453/26]
2041. Deputy Peter 'Chap' Cleere asked the Minister for Health if she will ensure that an urgent referral will be expedited by the consultants of a person (details supplied); and if she will make a statement on the matter. [42455/26]
2042. Deputy Paul Nicholas Gogarty asked the Minister for Health if there are plans to expand the reach of a centre (details supplied) to tackle the shortage in public health nurses who are able to provide developmental checks to children in the surrounding area; and if she will make a statement on the matter. [42456/26]
2043. Deputy Paul Nicholas Gogarty asked the Minister for Health if there are plans to provide further funding to adequately ensure that a centre (details supplied) is staffed in accordance with the population in the area; and if she will make a statement on the matter. [42457/26]
2044. Deputy Barry Ward asked the Minister for Health further to Parliamentary Question No. 355 of 21 May 2026, the medical basis on which the decision not to include type 2 diabetics who are insulin dependent in the HSE supports for continuous glucose monitoring; and if she will make a statement on the matter. [42476/26]
2045. Deputy Barry Ward asked the Minister for Health further to Parliamentary Question No. 355 of 21 May 2026, her Departmental policy on which the decision not to include type 2 diabetics who are insulin dependent in the HSE supports for continuous glucose monitoring; and if she will make a statement on the matter. [42477/26]
2046. Deputy Barry Ward asked the Minister for Health the parameters of the Diabetes Policy and Services Review: A Strategy for Better Care; if the qualifying criteria for the HSE supports for continuous glucose monitoring was considered; and if she will make a statement on the matter. [42478/26]
2047. Deputy Barry Ward asked the Minister for Health if there is a timeline in place for the implementation of the recommendations set out in the Diabetes Policy and Services Review: A Strategy for Better Care; and if she will make a statement on the matter. [42479/26]
2048. Deputy Ken O'Flynn asked the Minister for Health the estimated annual gross expenditure under the GMS, DPS, LTI and High-Tech Drug Scheme in each year since 2020; and what proportion of that expenditure has been subject to any formal medicines waste analysis. [42485/26]
2049. Deputy Ken O'Flynn asked the Minister for Health whether the forthcoming national medicines disposal programme will include medicine-level cataloguing, reimbursement category tracking, estimated retail value assessment, or analysis of prescribing source; and if she will make a statement on the matter. [42486/26]
2050. Deputy Ken O'Flynn asked the Minister for Health whether her Department or HSE has conducted any international benchmarking regarding medicines waste reduction strategies in comparable EU jurisdictions; and if so, to provide details. [42487/26]
2051. Deputy Ken O'Flynn asked the Minister for Health whether any estimate exists of medicines dispensed under State-funded schemes but not consumed due to non-adherence, therapy change, duplication, early discontinuation, death, hospital admission, or over-prescribing; and if she will make a statement on the matter. [42488/26]
2052. Deputy Ken O'Flynn asked the Minister for Health whether the HSE intends to publish annual reports arising from the new national medicines disposal programme, including estimated financial value and environmental impact of returned medicines. [42489/26]
2053. Deputy Ken O'Flynn asked the Minister for Health whether the proposed rare disease early-access framework will include formal eligibility criteria, maximum decision timelines, independent clinical oversight arrangements, and national equity safeguards; and if she will make a statement on the matter. [42490/26]
2054. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted any estimate of the potential annual cost exposure associated with a rare disease early-access framework; and if she will make a statement on the matter. [42491/26]
2055. Deputy Ken O'Flynn asked the Minister for Health whether any ethical or legal review has been conducted regarding prioritisation criteria within the proposed early-access framework for rare diseases; and if she will make a statement on the matter. [42492/26]
2056. Deputy Ken O'Flynn asked the Minister for Health whether patient registries or national prevalence datasets will form part of the planned rare disease reimbursement reforms; and if she will make a statement on the matter. [42493/26]
2057. Deputy Ruth Coppinger asked the Minister for Health the levels of staffing for community public health services in the Dublin 15 area; to report on whether all newborn children are receiving timely developmental checks; if all new parents are receiving their appropriate number of visits; and if she will make a statement on the matter. [42500/26]
2058. Deputy Ken O'Flynn asked the Minister for Health whether the absence of any national clinical audit relating to procedures funded under the Treatment Abroad Scheme since 2020 is considered acceptable from a patient-safety and governance perspective; and if she will make a statement on the matter. [42505/26]
2059. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any risk assessment regarding the absence of national clinical outcome auditing for procedures funded under the treatment abroad scheme; and if she will make a statement on the matter. [42506/26]